Home > Financial Ratios > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
Core EBITDA Growth

    Back to All Ratios
ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results

ASTRAZENECA PHARMA INDIA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 34.3714.6689.44-31.9410.94

What is the latest Core EBITDA Growth ratio of ASTRAZENECA PHARMA INDIA ?

The latest Core EBITDA Growth ratio of ASTRAZENECA PHARMA INDIA is 34.37 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar202534.37
Mar202414.66
Mar202389.44
Mar2022-31.94
Mar202110.94

How is Core EBITDA Growth of ASTRAZENECA PHARMA INDIA Trending?

Years Core EBITDA Growth % Change
Mar2025 34.37
134.45
Mar2024 14.66
-83.61
Mar2023 89.44
Positive
Mar2022 -31.94
Negative
Mar2021 10.94 -

Other Financial Ratios of ASTRAZENECA PHARMA INDIA


Compare Core EBITDA Growth ratio of peers of ASTRAZENECA PHARMA INDIA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA ₹22,845.9 Cr 1.3% -0.7% 37.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,513.0 Cr -0.1% 3.4% -0.1% Stock Analytics
DIVIS LABORATORIES ₹170,614.0 Cr 1.6% -2.5% 8.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,245.0 Cr 0.8% -0.9% 13.5% Stock Analytics
CIPLA ₹122,555.0 Cr 1.3% -0.6% 3.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,803.0 Cr 1% 3.7% 2.7% Stock Analytics


ASTRAZENECA PHARMA INDIA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA

1.3%

-0.7%

37.9%

SENSEX

-0.5%

1%

4.6%


You may also like the below Video Courses